CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

MMIT/Evaluate to Boost Pharma...

DNA Sequencing Evolving With Groundbreaking Technology

DNA Sequencing Evolving With...

How AI Can Impact Quality Management in Life Science

How AI Can Impact Quality Management...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

MMIT/Evaluate to Boost Pharma...

DNA Sequencing Evolving With Groundbreaking Technology

DNA Sequencing Evolving With...

How AI Can Impact Quality Management in Life Science

How AI Can Impact Quality Management...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Life Sciences Review Life Sciences Review | Monday, October 25, 2021
Tweet

Acquisition Provides Expertise in Artificial Intelligence and Data Engineering, Enterprise Analytics, and Technology-Enabled Solutions to Help Customers Perform Better


FREMONT, CA: “We are thrilled to welcome the RxDataScience team to the Syneos Health family. Combining our end-to-end services and deep behavioral and therapeutic expertise with their AI and data-science capabilities will generate customer strategies to accelerate product development and time to market,” states Alistair Macdonald, CEO, Syneos Health. Syneos Health®, the first fully-integrated biopharmaceutical solutions company, takes over RxDataScience, a market leader in healthcare-focused data analytics, data management, and artificial intelligence (AI). Syneos Health and RxDataScience will collaborate to offer biopharma customers technology-enabled, insight-driven solutions to speed performance across the product lifecycle, from lab to market.


The acquisition expands the company's offering of advanced solutions beyond simple reporting to complex platforms for Augmented Intelligent Insights and Biopharma Analytics. RxDataSciences' product lifecycle solutions include scientific computing for research and development, patient journey management, decentralized trials, RWE, predictive analytics, and commercial market research. RxDataScience provides an expedited consulting model that utilizes an iterative approach to rapidly build and deliver advanced analytics solution prototypes in six- to eight-week sprints.


 “This acquisition boosts our ability to deliver strategic insights and technology-enabled solutions that address our customers' most complex data challenges,” adds Macdonald.


RxDataScience expands Syneos Health's data science capabilities by bringing new capabilities and deep expertise in data engineering and management, as well as advanced enterprise analytics, to accelerate product and customer performance commercialization, with the potential to significantly shorten clinical trials and modernize medical affairs and commercial programs.


"RxDataScience has dedicated its first five years to building a vision, talent and technology that address challenges in data management, data science and AI faced by biopharma companies," says Sayee Natarajan, CEO, and Co-Founder, RxDataScience. "We're excited to join Syneos Health, giving us a tremendous opportunity to scale our services, expand our market and offer solutions to a larger customer base. We're particularly excited to be part of an ecosystem built on innovation and an entrepreneurial approach for delivering novel solutions and new capabilities to customers."


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/syneos-health-s-acquisition-of-rxdatascience-to-help-boost-product-development-nwid-607.html